期刊文献+

非酒精性脂肪肝患者肝酶与代谢综合征的关系 被引量:1

Association of Abnormality of Liver Enzymes and Metabolic Syndrome in Patients with Non-alcohoblic Fatty Liver Disease
下载PDF
导出
摘要 目的分析非酒精性脂肪肝病患者中肝酶与代谢综合征的关系。方法收集山西某电厂体检发现的NAFLD患者144例,测量身高、体重、腰臀围,检测丙氨酸转氨酶,血脂,空腹血糖。结果该人群中MS患病比例为39.58%,肝酶异常者52例占36.11%,其中MS中57例肝酶异常比例达48.08%。MS组肝酶高于非MS组。结论30%以上NAFLD患者存在肝酶异常,肝酶异常者中MS检出率明显增高。 Objective To investigate the changes of liver enzymes in the patients with non-alcoholic fatty liver disease and to analyze the association between liver enzymes and metabolic syndrome. Methods 144 patients with NAFLD underwent anthropometry,laboratory tests included alanine aminotransferase,serum lipid,fasting plasma glucose,and abdominal ultrasonography. Results 52 of the 144 NAFLD patients showed that have abnormal liver enzymes. 57 of the 144 NAFLD patients were diagnosed as with MS. 48.08%of those with abnormal liver enzymes were diagnosed as with MS, a percentage significantly higher than that of those without normal liver enzyme(P〈 0.05 ). The levels of the liver enzymes was higher in the group with MS than in the group without MS (P〈 0.05). Conclusion Most patients with NAFLD have abnormal liver enzymes, and the percentage of MS is higher in the abnormal liver enzyme group.
作者 辛丽红 杨静
出处 《中国现代医生》 2009年第8期67-68,共2页 China Modern Doctor
关键词 非酒精性脂肪肝 代谢综合征 肝功能 Non-alcoholic fatty liver disease Metabolic syndrome Liver function
  • 相关文献

参考文献5

二级参考文献30

  • 1胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量:108
  • 2Schwimmer JB,Behling C,Newbury R,et al.Histopathology of pediatric nonalcoholic fatty liver disease.Hepatology,2005,42:641-649.
  • 3Neuschwander Tetri BA,Caldwell SH.Nonalcoholic steatohepatitis:summary of an AASLD Single Topic Conference.Hepatology,2003,37:1202-1219.
  • 4Angulo P.Nonalcoholic fatty liver disease.N Engl J Med,2002,346:1221-1231.
  • 5Ghali P,Lindor KD.Hepatotoxicity of drugs used for treatment of obesity and its comorbidities.Semin Liver Dis,2004,24:389-397.
  • 6Harrison SA,Torgerson S,Hayashi P,et al.Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis.Am J Gastroenterol,2003,98:2485-2490.
  • 7Angulo P.Use of ursodeoxycholic acid in patients with liver disease.Curr Gastroenterol Rep,2002,4:37-44.
  • 8Agrawal S,Bonkovsky HL.Management of nonalcoholic steatohepatitis:an analytic review.J Clin Gastroenterol,2002,35:253-261.
  • 9Comar KM,Sterling RK.Drug therapy for non-alcoholic fatty liver disease.Aliment Pharmacal Ther,2006,23:207-215.
  • 10Lok AS,McMahon B J; Practice Guidelines Committee,American Association for the Study of Liver Diseases (AASLD).Chronic hepatitis B:update of recommendations.Hepatology,2004,39:857-861.

共引文献1622

同被引文献7

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部